Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
149.00    2.25 (1.53%)
Bid:
142.00
Ask:
149.00
Spread: 7.00 (4.93%)
Market Cap: £281.29m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

Share Purchase Programme

23 Dec 2022 07:00

RNS Number : 6672K
Franchise Brands PLC
23 December 2022
 

23 December 2022

FRANCHISE BRANDS PLC

 

("Franchise Brands", "the Group" or "the Company")

 

Share purchase programme

 

Franchise Brands plc (AIM: FRAN), a multi-brand franchise business, announces that it will continue its discretionary programme to buy ordinary shares of 0.5p each in the Company ("Ordinary Shares") for the next six-month period from 1 January 2023 to 30 June 2023, up to an aggregate value of £1,500,000 (the "Programme").

The Trustee of the Franchise Brands PLC Employee Benefit Trust (the "EBT") will purchase Ordinary Shares in accordance with the Programme. The Programme seeks to mitigate the dilutive impact of share option awards and to improve overall shareholder return.

During the period 24 June 2022 to 22 December 2022 ("the period"), the EBT has purchased 1,329,392 Ordinary Shares at an average price of £1.46 pence per share. 90,265 Ordinary Shares held by the EBT have been used to satisfy the exercise of options over Ordinary Shares. Accordingly, the EBT currently holds 1,774,915 Ordinary Shares (24 June 2022: 535,788 Ordinary Shares) which represents 1.36 per cent. (24 June 2022: 0.44 per cent.) of the Company's current issued share capital. The net cash cost to the Company during the period was £1,836,722.

The Trustees of the EBT have entered into arrangements with the Company's joint broker, Dowgate Capital Limited ("Dowgate"), to carry out on-market purchases of Ordinary Shares under the Programme, including on a discretionary basis independent of the Company during any prohibited periods of the Company, as determined by the UK Market Abuse Regulation, which may fall during the period of the Programme.

 

Enquiries:

 

Franchise Brands plc

+ 44 (0) 1625 813231

Stephen Hemsley, Executive Chairman

 

Andrew Mallows, Interim Chief Financial Officer

 

Julia Choudhury, Corporate Development Director

 

 

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 3328 5656

Jeremy Porter / George Payne (Corporate Finance)

Amrit Nahal (Sales & Corporate Broking)

 

 

 

Dowgate Capital Limited (Joint Broker)

+44 (0) 20 3903 7715

James Serjeant / Russell Cook / Nicholas Chambers

 

 

 

MHP (Financial PR)

+44 (0) 20 3128 8100

Katie Hunt/Catherine Chapman

+44 (0) 7884 494112

 

franchisebrands@mhpc.com

 

About Franchise Brands plc

 

Franchise Brands is focused on building market-leading businesses primarily via a franchise model. The Group currently has a combined network of 600 franchisees across six principal franchise brands in the UK, North America and Europe. Our focus is on established brands which can benefit from our shared support services, specialist sector expertise, management experience and group resources.

 

Our B2B brands are Metro Rod, Metro Plumb, Filta, Willow Pumps and Azura, and our principle B2C brands are ChipsAway, Ovenclean and Barking Mad. Each of our brands are leaders in their respective markets. The combined trading history of all the Group's brands is over 190 years. Franchise Brands employs over 430 people from 5 principal offices in the UK as well as Orlando, Florida and the Netherlands.

 

For further information, visit www.franchisebrands.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFFSFFLFFIF
Date   Source Headline
17th Mar 20257:00 amRNSNotice of Results
25th Feb 20253:47 pmRNSHolding(s) in Company
20th Feb 20252:30 pmRNSCapital Markets Day
13th Feb 20257:00 amRNSAppointment of CFO and Group Finance Director
11th Feb 20257:00 amRNSDirector/PDMR Shareholding
7th Feb 20257:00 amRNS-RCapital Markets Day
31st Jan 20257:00 amRNSDirectors’ dealings
28th Jan 20257:00 amRNSTrading Update
16th Jan 20257:00 amRNSAppointment of Non-Executive Director
13th Nov 20242:00 pmRNSGrant of Options to director
12th Nov 20247:00 amRNSQ3 Trading Update
23rd Oct 20247:00 amRNSGroup CEO Appointment and Listing Consideration
15th Oct 20247:00 amRNSRe-commencement of Share purchase programme
23rd Sep 202411:54 amRNSHolding(s) in Company
20th Sep 20247:00 amRNSDirector/PDMR shareholding & holding in Company
17th Sep 20247:00 amRNSInterim Results
9th Sep 20247:00 amRNSNotice of Interim Results
30th Jul 20248:33 amRNSDirector/PDMR Shareholding
18th Jul 20241:55 pmRNSResult of AGM
18th Jul 20247:00 amRNSAGM Statement and Trading Update
8th Jul 20241:42 pmRNSGrant of Options
27th Jun 202410:01 amRNSAnnual General Meeting and proxy voting deadline
21st Jun 20244:40 pmRNSPublication of Annual Report and Accounts
20th Jun 20247:01 amRNSBoard and management changes
20th Jun 20247:00 amRNSFinal Results
3rd Jun 20247:00 amRNSTrading Update, Final Dividend & AGM
4th Apr 20243:02 pmRNSHolding(s) in Company
20th Feb 20242:45 pmRNSCapital Markets Day
18th Jan 20247:00 amRNSCapital Markets Day
18th Jan 20247:00 amRNSTrading Update
16th Jan 20245:12 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSInvestor presentation
15th Nov 20233:11 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSQ3 Trading Update
4th Sep 20237:00 amRNSBoard and management update
4th Aug 20237:00 amRNSDirector/PDMR Shareholding and Grant of Options
27th Jul 20237:01 amRNSAppointment of Chief Financial Officer
27th Jul 20237:00 amRNSInterim Results
25th Jul 20231:51 pmRNSInvestor Presentation via Investor Meet Company
5th Jul 20237:00 amRNSNotice of Interim Results
26th Jun 20237:00 amRNSShare Purchase Programme
1st Jun 20237:00 amRNSDirector/PDMR Shareholding
18th May 202310:10 amRNSHolding(s) in Company
10th May 20235:54 pmRNSGrant of options & director holdings
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20235:00 pmRNSTotal Voting Rights
25th Apr 20234:09 pmRNSHolding(s) in Company
24th Apr 20231:55 pmRNSHolding(s) in Company
20th Apr 20239:33 amRNSResult of GM, Completion of Acquisition and TVR
18th Apr 20231:56 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.